☆ 4.7 Article

Maximal Effort Cytoreduction in Epithelial Ovarian Cancer: Perioperative Complications and Survival Outcomes from a Retrospective Cohort

JOURNAL OF CLINICAL MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Obstetrics & Gynecology

Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer

Sarah Mejer Sorensen et al.

Summary: The impact of primary debulking surgery (PDS) versus interval debulking surgery (IDS) on the overall survival (OS) of women with FIGO Stage IV epithelial ovarian cancer is debated. This study compared the outcomes of PDS and IDS in terms of the impact of intra-abdominal residual tumor, Stage IVA vs IVB, as well as the localization and number of metastases defining Stage IV disease. The results showed similar OS in patients with Stage IV disease treated with PDS and IDS. Complete intra-abdominal tumor resection improved the prognosis in both PDS and IDS. Malignant pleural effusion seemed to be a negative prognostic factor and should be further investigated in future studies.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2022)

添加到收藏夹

Article Obstetrics & Gynecology

Quality of life from cytoreductive surgery in advanced ovarian cancer: Investigating the association between disease burden and surgical complexity in the international, prospective, SOCQER-2 cohort study

Sudha Sundar et al.

Summary: This study aimed to investigate the quality of life (QoL) after surgical resection for advanced ovarian cancer and explore the association with surgical complexity and disease burden. The results showed that increasing surgical complexity did not lead to a decline in QoL. For patients with advanced ovarian cancer, higher surgical complexity was associated with greater improvement in postoperative QoL.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

添加到收藏夹

Article Oncology

Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece

Dimitrios Haidopoulos et al.

Summary: A retrospective study on pelvic exenteration for gynecologic malignancies revealed significant survival probability for patients, with positive margins increasing the risk of recurrence, but not affecting overall survival. Major complications were rare, although some patients required reoperation.

SURGICAL ONCOLOGY-OXFORD (2022)

添加到收藏夹

Article Oncology

Maximal surgical effort increases the risk of postoperative complications in the treatment of advanced ovarian cancer

Kati Kuusela et al.

Summary: This study assessed the impact of increased surgical radicality on the risk of complications in the treatment of advanced ovarian cancer, finding that more extensive surgeries led to better surgical results but increased postoperative morbidity. Postoperative complication rates were similar in both primary and interval debulking surgeries.

EJSO (2022)

添加到收藏夹

Article Surgery

Interval Debulking Surgery for Advanced Ovarian Cancer in Elderly Patients (≥70 y): Does the Age Matter?

Ciro Pinelli et al.

Summary: The study showed that elderly ovarian cancer patients had similar clinical outcomes to younger patients when receiving similar treatment, indicating that age should not be a limiting factor for offering ultra-radical resection to patients. Clinicians should actively use Cardiopulmonary Exercise Testing for patient selection.

JOURNAL OF INVESTIGATIVE SURGERY (2021)

添加到收藏夹

Article Oncology

Appropriate triage allows aggressive primary debulking surgery with rates of morbidity and mortality comparable to interval surgery after chemotherapy

Deepa M. Narasimhulu et al.

Summary: Using an evidence-based algorithm to identify patients fit for surgery in advanced epithelial ovarian cancer demonstrated that despite more complex surgery, patients undergoing primary debulking surgery had comparable morbidity and mortality outcomes to those undergoing interval debulking surgery, with similar rates of complete resection and overall survival.

GYNECOLOGIC ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Postoperative outcomes of primary and interval cytoreductive surgery for advanced ovarian cancer registered in the Dutch Gynecological Oncology Audit (DGOA)

N. M. S. Baldewpersad Tewarie et al.

Summary: The study found that patients undergoing primary debulking surgery had a higher rate of complete cytoreduction but also a higher rate of complications requiring re-intervention, resulting in a longer time to start adjuvant chemotherapy. It is important to balance the aggressiveness of surgery with the outcomes of severe complications to improve the quality of surgical outcomes.

GYNECOLOGIC ONCOLOGY (2021)

添加到收藏夹

Article Oncology

European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery

Christina Fotopoulou et al.

Summary: ESGO has developed quality indicators and consensus guidelines for advanced ovarian cancer surgery, as well as evidence-based guidelines for peri-operative care and management of complications, to improve the quality of care for women with advanced ovarian cancer. The guidelines are based on expert consensus and the best available evidence, and have been reviewed by international practitioners and patient representatives prior to publication.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2021)

添加到收藏夹

Article Oncology

Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis

V Ghirardi et al.

GYNECOLOGIC ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial

Takashi Onda et al.

EUROPEAN JOURNAL OF CANCER (2020)

添加到收藏夹

Article Oncology

Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850)

Anna Fagotti et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2020)

添加到收藏夹

Review Oncology

First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

Susana Banerjee et al.

ESMO OPEN (2020)

添加到收藏夹

Article Oncology

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

N. Colombo et al.

ANNALS OF ONCOLOGY (2019)

添加到收藏夹

Article Oncology

ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

N. Colombo et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)

添加到收藏夹

Article Oncology

Maximal-Effort Cytoreductive Surgery for Ovarian Cancer Patients with a High Tumor Burden: Variations in Practice and Impact on Outcome

Marcia Hall et al.

ANNALS OF SURGICAL ONCOLOGY (2019)

添加到收藏夹

Article Oncology

TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO-OVAR OP7)

Alexander Reuss et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)

添加到收藏夹

Article Oncology

Ovarian Cancer Statistics, 2018

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

添加到收藏夹

Article Oncology

Anti-angiogenic agents in ovarian cancer: past, present, and future

B. J. Monk et al.

ANNALS OF ONCOLOGY (2016)

添加到收藏夹

Article Obstetrics & Gynecology

Maximal effort cytoreductive surgery for disseminated ovarian cancer in a UK setting: challenges and possibilities

Christina Fotopoulou et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)

添加到收藏夹

Article Oncology

Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease

Pauline Wimberger et al.

ANNALS OF SURGICAL ONCOLOGY (2010)

添加到收藏夹

Article Medicine, General & Internal

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

Ignace Vergote et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

添加到收藏夹

Article Oncology

Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials By the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO)

Andreas du Bois et al.

CANCER (2009)

添加到收藏夹

Article Surgery

Quality Improvement in the Surgical Approach to Advanced Ovarian Cancer: The Mayo Clinic Experience

Giovanni D. Aletti et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)

添加到收藏夹

Article Obstetrics & Gynecology

Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer

Giovanni D. Aletti et al.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)

添加到收藏夹

Article Oncology

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach

DS Chi et al.

GYNECOLOGIC ONCOLOGY (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.